Cargando…
β-Galactosylceramidase in cancer: more than a psychosine scavenger
Autores principales: | Belleri, Mirella, Presta, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946824/ https://www.ncbi.nlm.nih.gov/pubmed/35340675 http://dx.doi.org/10.18632/oncoscience.551 |
Ejemplares similares
-
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019) -
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells
por: Capoferri, Davide, et al.
Publicado: (2023) -
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice
por: Coltrini, Daniela, et al.
Publicado: (2022) -
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease
por: Righi, Marco, et al.
Publicado: (2019) -
Inhibition of Cytokinesis by a Lipid Metabolite, Psychosine
por: Kanazawa, Takayuki, et al.
Publicado: (2000)